Fights Bacterial Inflammation in the Throat and Pharynx

Learn More

Is the first and unique medical device against Streptococcus pyogenes the main cause of sore throat.

SALVANS® is a patent containing a specific strain of Lactobacillus crispatus (DSMZ 25988)

  • Reduces the S. pyogenes bacterial load when advanced infection by its co-aggregation mechanism of action.
  • Protects your throat mucose from the S. pyogenes infections.
  • Salvans® improves the antibiotic therapy effectiveness.
  • Salvans® does not lead to bacterial resistance neither interacts with the microbiome.
  • Salvans® is QPS ingredient with no side-effects reported.

Is a unique therapy for sore throat super infection

 

SALVANS® Mechanism of Action

How does SALVANS® Work?

Reduces the S.pyogenes bacterial load by a highly specific and unique mode of action.

Slide 01

With a dosage of 10 mg SALVANS®

1

Co-aggregates to S. pyogenes inactivating their pathogenic activity.

Slide 02
2

The co-aggregates are propagated by the natural pharyngeal saliva flow and by swallowing.

Slide 03
3

The co-aggregates are finally destroyed in the acidic environment of the stomach.

Slide 04

Finally SALVANS®

4

Binds to the pharyngeal mucosa avoiding the pathogen infection.

Slide 05

SALVANS® available galenic forms

Throat Lozenges

THROAT LOZENGES

Medical Device

Drops

DROPS

Food Product

Microbiotics

MICROBIOTICS

Active Ingredient

 

Contact Us

Belano Medical AG, a Tradichem Company has developed SALVANS®

Labs